Cash flow BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 19/02/2026 am IST			5-day change	1st Jan Change
61.83 ^USD	+3.14%		+2.52%	+4.04%

18/02	Tarsus Pharmaceuticals, Inc. Appoints David E. I. Pyott to Its Board of Directors and Chairperson of Commercial Committee and as Member of Nominating Committee and Compensation Committee of the Board, Effective on February 18, 2026	CI
13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI

b0f4ee4a6702e2e6ec.0QsOEsHK0B9gqm_CgopKU5TqzYr8seDCd90zKOLiCjA.qTpPIaStiHI5zxuA2M88FsWk_-_R9dWUL-l7QZrSRGG6TV9AkL-5LQWYCA

Published financial data: BIOMARIN PHARMACEUTICAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	186.05Cr	184.63Cr	209.6Cr	241.92Cr	285.39Cr
Total Revenues	186.05Cr	184.63Cr	209.6Cr	241.92Cr	285.39Cr
Cost of Goods Sold, Total	115.24Cr	109.93Cr	113.33Cr	126.16Cr	58Cr
Gross Profit	71Cr	75Cr	96Cr	115.76Cr	227.37Cr
Selling General & Admin Expenses, Total	74Cr	76Cr	85Cr	92Cr	91Cr
R&D Expenses	-	-	-	-	75Cr
Amortization of Goodwill and Intangible Assets - (IS)	6.22Cr	6.19Cr	6.28Cr	6.22Cr	4.33Cr
Other Operating Expenses, Total	80Cr	82Cr	92Cr	99Cr	170.36Cr
Operating Income	-9.18Cr	-7.43Cr	4.6Cr	17Cr	57Cr
Interest Expense, Total	-2.93Cr	-1.53Cr	-1.6Cr	-1.73Cr	-1.27Cr
Interest And Investment Income	1.66Cr	1.05Cr	1.8Cr	5.83Cr	7.49Cr
Net Interest Expenses	-1.27Cr	-48.55L	20.64L	4.1Cr	6.22Cr
Income (Loss) On Equity Invest.	-6T	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-86L
Other Non Operating Income (Expenses)	65.96L	1.18Cr	-20.5L	1.4Cr	39.32L
EBT, Excl. Unusual Items	-9.79Cr	-6.73Cr	4.6Cr	23Cr	63Cr
Restructuring Charges	-	-	-	-	-9.58Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	6L	-	-	-1.26Cr	-
Gain (Loss) On Sale Of Assets	5.95Cr	-	11Cr	-	1Cr
Asset Writedown	-	-	-	-1.4Cr	-
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-45L	-80.26L	-43.99L	-1.19Cr	-
EBT, Incl. Unusual Items	-4.23Cr	-7.54Cr	15Cr	19Cr	54Cr
Income Tax Expense	-90Cr	-1.13Cr	80.15L	2.09Cr	11Cr
Earnings From Continuing Operations	86Cr	-6.41Cr	14Cr	17Cr	43Cr
Net Income to Company	86Cr	-6.41Cr	14Cr	17Cr	43Cr
Net Income - (IS)	86Cr	-6.41Cr	14Cr	17Cr	43Cr
Net Income to Common Incl Extra Items	86Cr	-6.41Cr	14Cr	17Cr	43Cr
Net Income to Common Excl. Extra Items	86Cr	-6.41Cr	14Cr	17Cr	43Cr
Per Share Items
Net EPS - Basic	4.75	-0.35	0.76	0.89	2.25
Basic EPS - Continuing Operations	4.75	-0.35	0.76	0.89	2.25
Basic Weighted Average Shares Outstanding	18Cr	18Cr	19Cr	19Cr	19Cr
Net EPS - Diluted	4.53	-0.35	0.75	0.87	2.21
Diluted EPS - Continuing Operations	4.53	-0.35	0.75	0.87	2.21
Diluted Weighted Average Shares Outstanding	19Cr	18Cr	19Cr	19Cr	20Cr
Normalized Basic EPS	-0.34	-0.23	0.16	0.76	2.06
Normalized Diluted EPS	-0.32	-0.23	0.15	0.74	1.99
Supplemental Items
EBITDA	1.34Cr	3.37Cr	15Cr	28Cr	67Cr
EBITA	-2.96Cr	-1.24Cr	11Cr	23Cr	61Cr
EBIT	-9.18Cr	-7.43Cr	4.6Cr	17Cr	57Cr
EBITDAR	2.63Cr	4.77Cr	16Cr	29Cr	68Cr
Total Revenues (As Reported)	186.05Cr	184.63Cr	209.6Cr	241.92Cr	285.39Cr
Effective Tax Rate - (Ratio)	2.13T	14.96	5.36	11.09	21.21
Current Domestic Taxes	-1.36Cr	-7L	1.79Cr	3.02Cr	4.12Cr
Current Foreign Taxes	10.42L	50.37L	4.22Cr	3.57Cr	1.77Cr
Total Current Taxes	-1.25Cr	43.38L	6.01Cr	6.59Cr	5.88Cr
Deferred Domestic Taxes	-5.04Cr	-3.11Cr	-8.44Cr	-7.88Cr	-72.83L
Deferred Foreign Taxes	-84Cr	1.55Cr	3.23Cr	3.38Cr	6.34Cr
Total Deferred Taxes	-89Cr	-1.56Cr	-5.21Cr	-4.5Cr	5.61Cr
Normalized Net Income	-6.12Cr	-4.21Cr	2.87Cr	14Cr	39Cr
Interest on Long-Term Debt	2.93Cr	1.53Cr	1.6Cr	1.73Cr	1.27Cr
Supplemental Operating Expense Items
Advertising Expense	-	-	-	2.78Cr	3.45Cr
Selling and Marketing Expenses	-	-	-	2.78Cr	3.45Cr
Research And Development Expense From Footnotes	63Cr	63Cr	65Cr	75Cr	75Cr
Net Rental Expense, Total	1.28Cr	1.4Cr	1.37Cr	1.42Cr	1.42Cr
Imputed Operating Lease Interest Expense	29.5L	15.2L	15.57L	17.47L	16.23L
Imputed Operating Lease Depreciation	98.91L	1.24Cr	1.21Cr	1.24Cr	1.25Cr
Stock-Based Comp., COGS (Total)	8.82Cr	8.96Cr	7.94Cr	8.33Cr	1.51Cr
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	5.95Cr
Stock-Based Comp., SG&A Exp. (Total)	10Cr	11Cr	12Cr	12Cr	13Cr
Total Stock-Based Compensation	19Cr	20Cr	20Cr	21Cr	20Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	65Cr	59Cr	72Cr	76Cr	94Cr
Short Term Investments	42Cr	43Cr	57Cr	32Cr	19Cr
Total Cash And Short Term Investments	106.54Cr	101.39Cr	129.15Cr	107.38Cr	113.77Cr
Accounts Receivable, Total	45Cr	37Cr	46Cr	63Cr	66Cr
Other Receivables	-	-	-	-	-
Total Receivables	45Cr	37Cr	46Cr	63Cr	66Cr
Inventory	70Cr	78Cr	89Cr	110.72Cr	123.27Cr
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	13Cr	11Cr	10Cr	14Cr	20Cr
Total Current Assets	234.22Cr	227.44Cr	275.15Cr	295.61Cr	323.24Cr
Gross Property Plant And Equipment	172.52Cr	180.25Cr	191.65Cr	197.93Cr	196.86Cr
Accumulated Depreciation	-64Cr	-72Cr	-80Cr	-87Cr	-89Cr
Net Property Plant And Equipment	108.96Cr	108.19Cr	111.43Cr	111.22Cr	107.68Cr
Long-term Investments	30Cr	54Cr	37Cr	62Cr	53Cr
Goodwill	20Cr	20Cr	20Cr	20Cr	20Cr
Other Intangibles, Total	42Cr	39Cr	34Cr	33Cr	33Cr
Deferred Tax Assets Long-Term	143.22Cr	144.91Cr	150.54Cr	154.58Cr	148.94Cr
Other Long-Term Assets, Total	7.46Cr	7.62Cr	9.88Cr	8.36Cr	14Cr
Total Assets	584.8Cr	600.33Cr	637.51Cr	684.16Cr	698.89Cr
Liabilities
Accounts Payable, Total	19Cr	19Cr	23Cr	32Cr	24Cr
Accrued Expenses, Total	26Cr	27Cr	29Cr	31Cr	33Cr
Current Portion of Long-Term Debt	-	-	-	49Cr	-
Current Portion of Leases	1.18Cr	1.05Cr	1.04Cr	87.79L	75.74L
Current Income Taxes Payable	96.61L	12.13L	1.62Cr	26.51L	1.26Cr
Unearned Revenue Current, Total	2L	69.56L	7L	46.2L	13.69L
Other Current Liabilities	2.23Cr	5.86Cr	3.68Cr	4Cr	1.88Cr
Total Current Liabilities	49Cr	54Cr	59Cr	117.7Cr	61Cr
Long-Term Debt	107.51Cr	107.91Cr	108.3Cr	59Cr	60Cr
Long-Term Leases	4.45Cr	3.38Cr	2.65Cr	3.81Cr	3.13Cr
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	13Cr	7.98Cr	7.35Cr	8.18Cr	9.76Cr
Total Liabilities	174.2Cr	173.26Cr	177.19Cr	189.01Cr	133.1Cr
Common Stock, Total	2L	2L	2L	2L	2L
Additional Paid In Capital	499.34Cr	519.15Cr	540.49Cr	561.16Cr	580.21Cr
Retained Earnings	-86Cr	-93Cr	-79Cr	-62Cr	-19Cr
Comprehensive Income and Other	-2.6Cr	47.43L	-1.27Cr	-3.86Cr	5.04Cr
Total Common Equity	410.6Cr	427.07Cr	460.32Cr	495.15Cr	565.8Cr
Total Equity	410.6Cr	427.07Cr	460.32Cr	495.15Cr	565.8Cr
Total Liabilities And Equity	584.8Cr	600.33Cr	637.51Cr	684.16Cr	698.89Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18Cr	18Cr	19Cr	19Cr	19Cr
ECS Total Common Shares Outstanding	18Cr	18Cr	19Cr	19Cr	19Cr
Book Value / Share	22.59	23.22	24.71	26.25	29.66
Tangible Book Value	349.25Cr	368.59Cr	406.84Cr	443Cr	513.44Cr
Tangible Book Value Per Share	19.22	20.04	21.84	23.49	26.92
Total Debt	113.14Cr	112.34Cr	111.99Cr	113.39Cr	63Cr
Net Debt	6.6Cr	11Cr	-17Cr	6.01Cr	-50Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.24Cr	2.6Cr	2.25Cr	3.01Cr	3.79Cr
Debt Equivalent Oper. Leases	10Cr	11Cr	11Cr	11Cr	11Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	7.67Cr	8.03Cr	13Cr	16Cr	15Cr
Inventories - Work In Process, Total	31Cr	42Cr	41Cr	57Cr	55Cr
Inventories - Finished Goods, Total	31Cr	28Cr	35Cr	38Cr	53Cr
Land - (BS)	9.04Cr	9.04Cr	9.08Cr	9.08Cr	9.08Cr
Buildings, Total	76Cr	77Cr	82Cr	86Cr	89Cr
Machinery, Total	64Cr	69Cr	74Cr	80Cr	79Cr
Full Time Employees	3.06T	3.04T	3.08T	3.4T	3.04T
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	86Cr	-6.41Cr	14Cr	17Cr	43Cr
Depreciation & Amortization - CF	4.3Cr	4.61Cr	3.92Cr	4.22Cr	5.31Cr
Amortization of Goodwill and Intangible Assets - (CF)	6.22Cr	6.19Cr	6.28Cr	6.22Cr	4.33Cr
Depreciation & Amortization, Total	11Cr	11Cr	10Cr	10Cr	9.64Cr
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-5.95Cr	-	-11Cr	-	-1Cr
(Gain) Loss on Sale of Investments - (CF)	6L	51.55L	30.43L	-92.28L	-83.45L
Asset Writedown & Restructuring Costs	-	-	-	3.86Cr	1.99Cr
Stock-Based Compensation (CF)	19Cr	20Cr	20Cr	21Cr	20Cr
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-79Cr	-78.75L	-6.26Cr	-1.27Cr	6.28Cr
Change In Accounts Receivable	-5.9Cr	6.56Cr	-8.2Cr	-19Cr	-5.79Cr
Change In Inventories	-6.12Cr	-3.51Cr	-6.83Cr	-16Cr	-6.35Cr
Change In Accounts Payable	-8.7Cr	1.57Cr	5.9Cr	6.89Cr	-3.22Cr
Change in Other Net Operating Assets	-1.72Cr	1.98Cr	-51.04L	-5.79Cr	-6.27Cr
Cash from Operations	8.54Cr	30Cr	18Cr	16Cr	57Cr
Capital Expenditure	-11Cr	-9.56Cr	-12Cr	-9.67Cr	-8.54Cr
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	4.4Cr	-2.36Cr	9.27Cr	-1.09Cr	-19.94L
Investment in Marketable and Equity Securities, Total	2.62Cr	-25Cr	81.86L	-36.33L	22Cr
Other Investing Activities, Total	-94.32L	-10L	-	-	11.41L
Cash from Investing	-5.36Cr	-37Cr	-2Cr	-11Cr	14Cr
Long-Term Debt Issued, Total	59Cr	-	-	-	-
Total Debt Issued	59Cr	-	-	-	-
Long-Term Debt Repaid, Total	-38Cr	-30.39L	-26.05L	-22.86L	-49Cr
Total Debt Repaid	-38Cr	-30.39L	-26.05L	-22.86L	-49Cr
Issuance of Common Stock	7.19Cr	4.92Cr	6.93Cr	6.94Cr	4.93Cr
Repurchase of Common Stock	-9.46Cr	-4.58Cr	-5.43Cr	-7.63Cr	-7.76Cr
Other Financing Activities, Total	-	-4L	-3.11Cr	-94.75L	-31.77L
Cash from Financing	18Cr	-48T	-1.86Cr	-1.87Cr	-53Cr
Foreign Exchange Rate Adjustments	-11.5L	-57T	32T	13.08L	48.3L
Net Change in Cash	21Cr	-6.19Cr	14Cr	3.06Cr	19Cr
Supplemental Items
Cash Interest Paid	1.22Cr	1.04Cr	1.03Cr	1.03Cr	1.04Cr
Cash Income Tax Paid (Refund)	89.77L	1.82Cr	5.44Cr	7.33Cr	5.73Cr
Levered Free Cash Flow	-1.88Cr	19Cr	13Cr	-2.59Cr	27Cr
Unlevered Free Cash Flow	-5L	20Cr	14Cr	-1.51Cr	28Cr
Change In Net Working Capital	17Cr	-6.49Cr	16Cr	33Cr	29Cr
Net Debt Issued / Repaid	20Cr	-30.39L	-26.05L	-22.86L	-49Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-1.09	-0.78	0.46	1.63	5.15
Return on Total Capital	-1.24	-0.87	0.52	1.82	5.76
Return On Equity %	23.77	-1.53	3.19	3.51	8.05
Return on Common Equity	23.77	-1.53	3.19	3.51	8.05
Margin Analysis
Gross Profit Margin %	38.06	40.46	45.93	47.85	79.67
SG&A Margin	39.65	41.13	40.74	38.16	32
EBITDA Margin %	0.72	1.83	7.06	11.43	23.35
EBITA Margin %	-1.59	-0.67	5.19	9.68	21.49
EBIT Margin %	-4.93	-4.03	2.19	7.11	19.97
Income From Continuing Operations Margin %	46.18	-3.47	6.75	6.93	14.96
Net Income Margin %	46.18	-3.47	6.75	6.93	14.96
Net Avail. For Common Margin %	46.18	-3.47	6.75	6.93	14.96
Normalized Net Income Margin	-3.29	-2.28	1.37	5.87	13.74
Levered Free Cash Flow Margin	-1.01	10.56	6.29	-1.07	9.51
Unlevered Free Cash Flow Margin	-0.02	11.08	6.77	-0.62	9.79
Asset Turnover
Asset Turnover	0.35	0.31	0.34	0.37	0.41
Fixed Assets Turnover	1.72	1.7	1.91	2.17	2.61
Receivables Turnover (Average Receivables)	4.51	4.49	5.02	4.42	4.41
Inventory Turnover (Average Inventory)	1.67	1.49	1.36	1.26	0.5
Short Term Liquidity
Current Ratio	4.76	4.21	4.67	2.51	5.33
Quick Ratio	3.07	2.57	2.98	1.45	2.96
Operating Cash Flow to Current Liabilities	0.17	0.56	0.3	0.14	0.94
Days Sales Outstanding (Average Receivables)	81.22	81.23	72.68	82.61	82.99
Days Outstanding Inventory (Average Inventory)	218.96	244.91	269.05	289.49	737.96
Average Days Payable Outstanding	67.6	59.59	62.88	67.66	142.86
Cash Conversion Cycle (Average Days)	232.59	266.55	278.85	304.44	678.09
Long Term Solvency
Total Debt/Equity	27.55	26.3	24.33	22.9	11.2
Total Debt / Total Capital	21.6	20.83	19.57	18.63	10.08
LT Debt/Equity	27.27	26.06	24.1	12.75	11.07
Long-Term Debt / Total Capital	21.38	20.63	19.39	10.37	9.96
Total Liabilities / Total Assets	29.79	28.86	27.79	27.63	19.04
EBIT / Interest Expense	-3.13	-4.85	2.88	9.93	45.01
EBITDA / Interest Expense	0.9	3.11	10.12	16.77	53.74
(EBITDA - Capex) / Interest Expense	-3	-3.12	2.54	11.19	46.99
Total Debt / EBITDA	43.1	23.56	6.93	3.9	0.93
Net Debt / EBITDA	2.51	2.3	-1.06	0.21	-0.74
Total Debt / (EBITDA - Capex)	-12.85	-23.46	27.56	5.85	1.07
Net Debt / (EBITDA - Capex)	-0.75	-2.29	-4.22	0.31	-0.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.18	-0.76	13.53	15.42	17.97
Gross Profit, 1 Yr. Growth %	12.47	5.49	28.89	20.24	20.48
EBITDA, 1 Yr. Growth %	2.93T	151.45	338.65	61.75	129.69
EBITA, 1 Yr. Growth %	-42.44	-58	-976.05	77.82	147.34
EBIT, 1 Yr. Growth %	-12.49	-19.01	-161.85	149.55	206.85
Earnings From Cont. Operations, 1 Yr. Growth %	-3.7T	-107.46	-320.91	18.43	154.62
Net Income, 1 Yr. Growth %	-3.7T	-107.46	-320.91	18.43	154.62
Normalized Net Income, 1 Yr. Growth %	-1.35	-31.21	-168.29	229.19	211.98
Diluted EPS Before Extra, 1 Yr. Growth %	-3.5T	-107.74	-314.01	16	153.71
Accounts Receivable, 1 Yr. Growth %	18.8	-16.72	23.54	37.37	4.23
Inventory, 1 Yr. Growth %	2.69	11.18	15.12	23.83	11.33
Net Property, Plant and Equip., 1 Yr. Growth %	1.8	-0.71	3	-0.19	-3.18
Total Assets, 1 Yr. Growth %	24.69	2.66	6.17	7.32	2.15
Tangible Book Value, 1 Yr. Growth %	41.47	5.54	10.53	8.89	15.9
Common Equity, 1 Yr. Growth %	31.5	4.01	7.91	7.57	14.27
Cash From Operations, 1 Yr. Growth %	76.88	256.75	-42.24	-9.46	259.69
Capital Expenditures, 1 Yr. Growth %	-21.18	-16.39	26.56	-20.06	-11.65
Levered Free Cash Flow, 1 Yr. Growth %	-85.91	-1.14T	-34.59	-117.71	-1.67T
Unlevered Free Cash Flow, 1 Yr. Growth %	-99.62	-45.45T	-32.83	-109.64	-4.39T
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.7	4.09	6.14	14.47	16.69
Gross Profit, 2 Yr. CAGR %	21.5	8.92	16.61	24.49	19.47
EBITDA, 2 Yr. CAGR %	-52.46	772.5	232.11	186.33	106.27
EBITA, 2 Yr. CAGR %	-51.32	-50.83	91.82	334.42	128.49
EBIT, 2 Yr. CAGR %	-23.06	-15.81	-29.23	52.18	222.88
Earnings From Cont. Operations, 2 Yr. CAGR %	233.57	63.92	-59.29	61.75	73.65
Net Income, 2 Yr. CAGR %	233.57	63.92	-59.29	61.75	73.65
Normalized Net Income, 2 Yr. CAGR %	-25.05	-17.62	-31.46	83.65	280.8
Diluted EPS Before Extra, 2 Yr. CAGR %	220.86	62.2	-59.17	57.56	71.55
Accounts Receivable, 2 Yr. CAGR %	14.39	-0.53	1.44	30.27	19.66
Inventory, 2 Yr. CAGR %	14.71	6.85	13.13	19.4	17.42
Net Property, Plant and Equip., 2 Yr. CAGR %	7.17	0.54	1.13	1.39	-1.7
Total Assets, 2 Yr. CAGR %	14.93	13.14	4.41	6.74	4.7
Tangible Book Value, 2 Yr. CAGR %	23.79	22.19	7.93	9.71	12.34
Common Equity, 2 Yr. CAGR %	17.62	16.95	5.88	7.74	10.87
Cash From Operations, 2 Yr. CAGR %	105.53	151.2	43.55	-27.68	80.46
Capital Expenditures, 2 Yr. CAGR %	-11.09	-18.82	2.87	0.58	-15.96
Levered Free Cash Flow, 2 Yr. CAGR %	-47.22	20.98	165.07	-64.16	40.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	-89.39	31.36	1.67T	-73.29	37.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.3	7.38	7.15	9.15	15.62
Gross Profit, 3 Yr. CAGR %	15.37	15.91	15.21	17.8	44.92
EBITDA, 3 Yr. CAGR %	-31.37	-17.17	593.77	174.19	170.36
EBITA, 3 Yr. CAGR %	-31.79	-53.66	28.42	99.38	266.93
EBIT, 3 Yr. CAGR %	-9.44	-21.74	-24.04	23.32	97.22
Earnings From Cont. Operations, 3 Yr. CAGR %	94.34	-6.02	81.06	-41.88	88.16
Net Income, 3 Yr. CAGR %	94.34	-6.02	81.06	-41.88	88.16
Normalized Net Income, 3 Yr. CAGR %	-12.88	-27.16	-22.62	32.38	110.46
Diluted EPS Before Extra, 3 Yr. CAGR %	88.93	-7.27	77.9	-42.17	84.68
Accounts Receivable, 3 Yr. CAGR %	19.71	2.91	6.92	12.22	20.94
Inventory, 3 Yr. CAGR %	13.66	13.52	9.54	16.59	16.65
Net Property, Plant and Equip., 3 Yr. CAGR %	6.71	4.48	1.35	0.69	-0.16
Total Assets, 3 Yr. CAGR %	8.07	10.69	10.77	5.37	5.19
Tangible Book Value, 3 Yr. CAGR %	18.59	17.38	18.12	8.25	11.73
Common Equity, 3 Yr. CAGR %	13.49	12.9	13.81	6.44	9.87
Cash From Operations, 3 Yr. CAGR %	113.62	147	53.89	23.1	23.44
Capital Expenditures, 3 Yr. CAGR %	-16.9	-12.9	-5.87	-5.43	-3.67
Levered Free Cash Flow, 3 Yr. CAGR %	-41.99	42.5	-0.33	11.33	10.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	-81.34	72.16	6.17	222.05	9.79
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.89	10.58	9.8	10.16	10.86
Gross Profit, 5 Yr. CAGR %	47.02	24.94	15.86	19.27	29.28
EBITDA, 5 Yr. CAGR %	-44.85	-27.17	28.95	36.03	331.99
EBITA, 5 Yr. CAGR %	-37.06	-44.29	3.15	13.44	64.22
EBIT, 5 Yr. CAGR %	-21.61	-22.24	-17.95	2.11	40.3
Earnings From Cont. Operations, 5 Yr. CAGR %	37.98	-36.69	3.88	16.77	78.06
Net Income, 5 Yr. CAGR %	37.98	-36.69	3.88	16.77	78.06
Normalized Net Income, 5 Yr. CAGR %	-22.67	-25.28	-20.85	5.44	44.62
Diluted EPS Before Extra, 5 Yr. CAGR %	33.34	-37.95	2.25	14.63	75.34
Accounts Receivable, 5 Yr. CAGR %	22.14	11.64	12.03	13.09	11.85
Inventory, 5 Yr. CAGR %	20.79	16.94	13.45	15.84	12.62
Net Property, Plant and Equip., 5 Yr. CAGR %	9.12	6.26	4.44	3.23	0.12
Total Assets, 5 Yr. CAGR %	9.41	8.33	6.59	9.1	8.3
Tangible Book Value, 5 Yr. CAGR %	18.11	12.83	14.2	14.22	15.77
Common Equity, 5 Yr. CAGR %	11.33	9.07	10.39	10.78	12.63
Cash From Operations, 5 Yr. CAGR %	-17.21	5.97	82.21	51.12	64.02
Capital Expenditures, 5 Yr. CAGR %	-12.87	-8.42	-9.5	-7.74	-10.04
Levered Free Cash Flow, 5 Yr. CAGR %	-25.75	-6.21	6.53	-17.4	15.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	-62.31	-3.47	15.36	-17.77	18.71